Company page

Uniqure N.v.

Uniqure N.V. is a public company traded on the American market under the ticker QURE. With a market capitalization of approximately $2.74 billion, Uniqure focuses on developing gene therapies for genetic diseases. The company is committed to advancing innovative treatment options to improve patient outcomes.